Literature DB >> 31339773

Sex-related differences in the intratubular renin-angiotensin system in two-kidney, one-clip hypertensive rats.

Sang Ho Lee1, Yu Ho Lee1, Su Woong Jung1, Dong Jin Kim1, Seon Hwa Park1, Seok Jong Song1, Kyung Hwan Jeong1, Ju Young Moon1, Chun-Gyoo Ihm1, Tae Won Lee1, Jin Sug Kim1, Il Suk Sohn2, So-Young Lee3, Dong-Ok Kim4, Yang Gyun Kim1.   

Abstract

The intratubular renin-angiotensin system (RAS) is thought to play an essential role in hypertensive renal disease, but information regarding sex-related differences in this system is limited. The present study investigated sex differences in the intratubular RAS in two-kidney, one-clip (2K1C) rats. A 2.5-mm clip was placed on the left renal artery of Sprague-Dawley rats, and rats were euthanized 3 or 5 wk after the operation. Systolic blood pressure increased in 2K1C rats in both sexes but was significantly higher in male rats than in female rats, and an antihypertensive effect was not observed in 2K1C ovariectomized (OVX) female rats. Compared with male 2K1C rats, intratubular angiotensin-converting enzyme (ACE) and ANG II were repressed, and intratubular ACE2, angiotensin (1-7), and Mas receptor were increased in both kidneys in female 2K1C rats 5 wk after surgery. Comparison with male and female rats and intratubular mRNA levels of ACE and ANG II type 1 receptor were augmented in OVX female rats, regardless of the clipping surgery 3 wk postoperation. ANG II type 2 receptor was upregulated in female rats with or without OVX; thus, the ANG II type 1-to-type 2 receptor ratio was higher in male rats than in female rats. In conclusion, female rats were protected from hypertensive renal and cardiac injury after renal artery clipping. An increase in the intratubular nonclassic RAS [ACE2/angiotensin (1-7)/Mas receptor] and a decrease in the ANG II type 1-to-type 2 receptor ratio could limit the adverse effects of the classic RAS during renovascular hypertension in female rats, and estrogen is suggested to play a primary role in the regulation of intratubular RAS components.

Entities:  

Keywords:  intrarenal renin-angiotensin system; sex-related differences; two-kidney, one-clip rat

Year:  2019        PMID: 31339773     DOI: 10.1152/ajprenal.00451.2018

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  6 in total

1.  A new mechanism for the sex differences in angiotensin II-induced hypertension: the role of macula densa NOS1β-mediated tubuloglomerular feedback.

Authors:  Jie Zhang; Larry Qu; Jin Wei; Shan Jiang; Lan Xu; Lei Wang; Feng Cheng; Kun Jiang; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2020-10-12

2.  Estradiol Supplement or Induced Hypertension May Attenuate the Angiotensin II Type 1 Receptor Antagonist-Promoted Renal Blood Flow Response to Graded Angiotensin II Administration in Ovariectomized Rats.

Authors:  Samira Choopani; Mehdi Nematbakhsh
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-07-01       Impact factor: 4.109

3.  Nobiletin resolves left ventricular and renal changes in 2K-1C hypertensive rats.

Authors:  Metee Iampanichakul; Anuson Poasakate; Prapassorn Potue; Siwayu Rattanakanokchai; Putcharawipa Maneesai; Parichat Prachaney; Wannapa Settheetham-Ishida; Poungrat Pakdeechote
Journal:  Sci Rep       Date:  2022-06-03       Impact factor: 4.996

4.  Sex Differences in the Renal Vascular Responses of AT1 and Mas Receptors in Two-Kidney-One-Clip Hypertension.

Authors:  Zahra Pezeshki; Mehdi Nematbakhsh
Journal:  Int J Hypertens       Date:  2021-02-20       Impact factor: 2.420

5.  Renal Vascular Response to Angiotensin II Administration in Two Kidneys-One Clip Hypertensive Rats Treated with High Dose of Estradiol: The Role of Mas Receptor.

Authors:  Samira Choopani; Mehdi Nematbakhsh
Journal:  Int J Vasc Med       Date:  2021-03-01

Review 6.  Sex Difference in MasR Expression and Functions in the Renal System.

Authors:  Samira Choopani; Mehdi Nematbakhsh
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-09-10       Impact factor: 4.109

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.